Assessment of potential pharmacokinetic interactions of ezetimibe/simvastatin and extended-release niacin tablets in healthy subjects

Summary of the Second Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel II)

Scott M. Grundy · JAMA · 1993 · 27.9K citations

Metabolic Syndrome, Hypertension, Second Report +12

Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) Final Report

Circulation · 2002 · 13.9K citations

Health Policy, Cardiovascular Disease, Expert Panel +6

Detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III)

Scott M. Grundy, Diane M. Becker, Luther T. Clark et al. · Civil War Book Review · 2002 · 12.2K citations

Cardiovascular Disease, High Blood Cholesterol, Hyperlipidemia +4

Lipid-Altering Efficacy and Safety of Ezetimibe/Simvastatin Coadministered With Extended-Release Niacin in Patients With Type IIa or Type IIb Hyperlipidemia

John R. Guyton, B. Greg Brown, Sergio Fazio et al. · Journal of the American College of Cardiology · 2008 · 96 citations

Extended-release Niacin, Lipid Disorder, Ezetimibe/simvastatin Coadministered +8

Comparison of the Safety and Efficacy of a Combination Tablet of Niacin Extended Release and Simvastatin vs Simvastatin Monotherapy in Patients With Increased Non–HDL Cholesterol (from the SEACOAST I Study)

Christie M. Ballantyne, Michael H. Davidson, James M. McKenney et al. · The American Journal of Cardiology · 2008 · 92 citations

Lipid Disorder, Cardiovascular Disease, Medicine +6